ATE263556T1 - Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose - Google Patents

Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose

Info

Publication number
ATE263556T1
ATE263556T1 AT99965840T AT99965840T ATE263556T1 AT E263556 T1 ATE263556 T1 AT E263556T1 AT 99965840 T AT99965840 T AT 99965840T AT 99965840 T AT99965840 T AT 99965840T AT E263556 T1 ATE263556 T1 AT E263556T1
Authority
AT
Austria
Prior art keywords
restenosis
atherosclerosis
phenylesacetic
prevention
acid
Prior art date
Application number
AT99965840T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Application granted granted Critical
Publication of ATE263556T1 publication Critical patent/ATE263556T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99965840T 1998-11-23 1999-11-19 Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose ATE263556T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/197,903 US6127419A (en) 1998-11-23 1998-11-23 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
PCT/US1999/027480 WO2000030627A2 (en) 1998-11-23 1999-11-19 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis

Publications (1)

Publication Number Publication Date
ATE263556T1 true ATE263556T1 (de) 2004-04-15

Family

ID=22731212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99965840T ATE263556T1 (de) 1998-11-23 1999-11-19 Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose

Country Status (10)

Country Link
US (1) US6127419A (de)
EP (1) EP1171110B1 (de)
JP (1) JP4536258B2 (de)
AT (1) ATE263556T1 (de)
AU (1) AU757114B2 (de)
CA (1) CA2345409C (de)
DE (1) DE69916330T2 (de)
ES (1) ES2219102T3 (de)
HK (1) HK1045253B (de)
WO (1) WO2000030627A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53113032A (en) * 1977-03-09 1978-10-03 Mitsubishi Chem Ind Ltd Immune depresants
JPS54160740A (en) * 1978-06-09 1979-12-19 Takeda Chem Ind Ltd Anti-fibrotic agent
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
GB9027200D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US5705507A (en) * 1995-03-10 1998-01-06 Eli Lilly And Company Aplha-substituted-3-benzyl-benzofurans
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate

Also Published As

Publication number Publication date
HK1045253A1 (en) 2002-11-22
AU2152800A (en) 2000-06-13
WO2000030627A2 (en) 2000-06-02
HK1045253B (zh) 2004-08-13
WO2000030627A3 (en) 2000-11-23
CA2345409C (en) 2008-09-09
EP1171110B1 (de) 2004-04-07
AU757114B2 (en) 2003-02-06
EP1171110A2 (de) 2002-01-16
US6127419A (en) 2000-10-03
CA2345409A1 (en) 2000-06-02
DE69916330D1 (de) 2004-05-13
DE69916330T2 (de) 2005-03-17
ES2219102T3 (es) 2004-11-16
JP4536258B2 (ja) 2010-09-01
JP2002530328A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
ATE430568T1 (de) Verfahren und zusammensetzungen zur vorbeugung oder behandlung von atherosclerose, restenose und zusammenhängenden erkrankungen
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DE69909818D1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
NO20083958L (no) Prodrugs av GABA-analoger, sammensetninger og anvendelse derav
ES2108120T3 (es) Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
EA200600618A1 (ru) Применение эффекторов глутаминил- и глутаматциклаз
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
NO20003018L (no) Triazinangiogenese-inhibitorer
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE238981T1 (de) Antitumorwirkstoffe
BR9408305A (pt) Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
DE69934113D1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
ATE554764T1 (de) Wirkungsvolle vereinfachte derivate von immunosuppressiva
DE60112872D1 (de) Phenylessigsäure-Zusammensetzungen zur Behandlung oder Vorbeugung von Hypercholesterolemia
ATE263566T1 (de) Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom
ATE334982T1 (de) 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1171110

Country of ref document: EP